These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22312844)

  • 1. [Genital warts and HPV vaccination].
    Pilka R; Dvorák V; Fait T
    Ceska Gynekol; 2011 Dec; 76(6):468-70. PubMed ID: 22312844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
    Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
    Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
    Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
    Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
    PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.
    Woodhall SC; Jit M; Cai C; Ramsey T; Zia S; Crouch S; Birks Y; Newton R; Edmunds WJ; Lacey CJ
    Sex Transm Dis; 2009 Aug; 36(8):515-21. PubMed ID: 19543143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J; Perkins N
    N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
    Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients.
    Dahlstrom KR; Fu S; Chan W; Shelal Z; Ramondetta LM; Lairson DR
    Pharmacoeconomics; 2018 Nov; 36(11):1355-1365. PubMed ID: 30019118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
    BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What can surveillance of genital warts tell us?
    Fairley CK; Donovan B
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
    Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
    BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the cost of genital warts: a study from Ireland.
    Dee A; Howell F; O'Connor C; Cremin S; Hunter K
    Sex Transm Infect; 2009 Sep; 85(5):402-3. PubMed ID: 19004863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males.
    Korostil IA; Ali H; Guy RJ; Donovan B; Law MG; Regan DG
    Sex Transm Dis; 2013 Nov; 40(11):833-5. PubMed ID: 24113401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns and associated costs for genital warts in Italy.
    Merito M; Largeron N; Cohet C; Timelli L; Boselli F; Matteelli A; Naldi L; Vittori G
    Curr Med Res Opin; 2008 Nov; 24(11):3175-83. PubMed ID: 18851777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
    Ali H; McManus H; O'Connor CC; Callander D; Kong M; Graham S; Saulo D; Fairley CK; Regan DG; Grulich A; Low N; Guy RJ; Donovan B
    Med J Aust; 2017 Mar; 206(5):204-209. PubMed ID: 28301790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
    Dominiak-Felden G; Gobbo C; Simondon F
    PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the monovalent to the nine-valent HPV vaccine.
    Pils S; Joura EA
    Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
    Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
    JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.